| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 52,546 | 67,833 | 38,997 | | Cost of Revenue | 54,039 | 56,978 | 33,352 | | | Gross Profit | (1,493) | 10,854 | 5,645 | | | Operating Expenses | | Research Development | 141 |
-
|
-
| | Selling General and Administrative | 3,774 | 4,336 | 1,925 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,408) | 6,519 | 3,720 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,340 | (30) | 353 | | Earnings Before Interest And Taxes | (4,068) | 6,489 | 4,073 | | Interest Expense | 1,096 | 516 | 238 | | Income Before Tax | (5,164) | 5,973 | 3,835 | | Income Tax Expense | (1,435) | 1,933 | 817 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,729) | 4,040 | 3,018 | | | Non-recurring Events | | Discontinued Operations |
-
| 23 |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (3,729) | 4,063 | 3,018 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,729) | $4,063 | $3,018 |
|
0.29% Nasdaq 
0.06 (5.88%) 
Income Statement
